tamsulosin has been researched along with Urinary Tract Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, G; Connolly, PJ; Li, S; Liu, J; Middleton, SA; Pulito, V | 1 |
| Loran, OB; Seregin, AA | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Wyndaele, JJ | 1 |
| Chiu, B; Chuang, YC; Chung, SD; Kuo, HC | 1 |
| Nickel, JC | 1 |
| de la Rosette, JJ; Michel, MC | 1 |
| Lowe, FC | 1 |
| Busse, M; Gross, AJ; Leonard, J; Schumacher, H | 1 |
| Athanasopoulos, A; Perimenis, P | 1 |
| Bondarenko, B; Engelmann, U; Funk, P; Schläfke, S; Walther, C | 1 |
| Baert, L; Chapple, CR; Höfner, K; Khoe, GS; Spångberg, A; Thind, P | 1 |
| Jarvis, B; Lyseng-Williamson, KA; Wagstaff, AJ | 1 |
| Chess-Williams, R | 1 |
| Dunn, CJ; Faulds, DM; Matheson, A | 1 |
7 review(s) available for tamsulosin and Urinary Tract Diseases
| Article | Year |
|---|---|
The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatic Hyperplasia; Prostatitis; Radiotherapy; Sulfonamides; Tamsulosin; Urologic Diseases; Urologic Surgical Procedures | 2003 |
Efficacy and safety of tamsulosin in the treatment of urological diseases.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urologic Diseases | 2004 |
Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Tract; Urologic Diseases | 2004 |
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
Tamsulosin: an update of its role in the management of lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Animals; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urologic Diseases | 2002 |
The use of alpha-adrenoceptor antagonists in lower urinary tract disease.
Topics: Adrenergic alpha-Antagonists; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urologic Diseases | 2002 |
Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder; Urologic Diseases | 2002 |
2 trial(s) available for tamsulosin and Urinary Tract Diseases
| Article | Year |
|---|---|
[The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)].
Topics: Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Recovery of Function; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urologic Diseases | 2018 |
Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin.
Topics: Adrenergic alpha-Antagonists; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Plant Extracts; Prospective Studies; Serenoa; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urodynamics; Urologic Diseases; Urticaceae | 2006 |
6 other study(ies) available for tamsulosin and Urinary Tract Diseases
| Article | Year |
|---|---|
(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding Sites; Cloning, Molecular; Humans; Ligands; Male; Models, Chemical; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Structure-Activity Relationship; Sulfonamides; Urologic Diseases | 2007 |
Drugs for urologic disorders.
Topics: Acetanilides; Azasteroids; Drug Combinations; Dutasteride; Ferric Compounds; Gels; Humans; Injections; Maltose; Mandelic Acids; Sulfonamides; Tamsulosin; Thiazoles; Urologic Diseases; Urological Agents | 2015 |
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases | 2009 |
Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of
Topics: Adrenergic alpha-Antagonists; Calcinosis; Humans; Inflammation; Male; Middle Aged; Prostate; Prostatic Diseases; Prostatitis; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urologic Diseases | 2009 |
Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Phytotherapy; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Treatment Outcome; Urologic Diseases | 2005 |
Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Pulse; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfonamides; Tamsulosin; Urologic Diseases | 1997 |